GoodRx Holdings, Inc. (GDRX) 의 후행 P/E는 23.6, 선행 P/E 7.1. 후행 이익수익률은 4.23%, 선행 이익수익률 14.18%. PEG 0.21 (Peter Lynch 저평가 ≤1.0). 그레이엄 넘버는 $1.91.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 57/100 2/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | -2,503.5 | 0.00 | 2,400.04 | 195.84 | - |
| 2017 | 2,200.8 | -10.31 | -225.80 | 123.77 | - |
| 2018 | 410.6 | 0.97 | -15.47 | 72.06 | 7.49% |
| 2019 | 272.2 | 0.00 | -16.53 | 46.32 | - |
| 2020 | -37.7 | 0.04 | 15.58 | 20.12 | - |
| 2021 | -530.5 | 5.62 | 16.11 | 17.97 | - |
| 2022 | -58.6 | -1.76 | 2.36 | 2.51 | - |
| 2023 | -310.0 | 4.25 | 3.61 | 3.66 | - |
| 2024 | 109.4 | -0.37 | 2.48 | 2.26 | - |
| 2025 | 31.7 | 0.31 | 1.57 | 1.21 | - |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $-0.02 | $99.38M | $-7.77M | -7.8% |
| 2017 | $0.02 | $157.24M | $8.84M | 5.6% |
| 2018 | $0.12 | $249.52M | $43.79M | 17.6% |
| 2019 | $0.11 | $388.22M | $66.05M | 17% |
| 2020 | $-0.75 | $550.7M | $-293.62M | -53.3% |
| 2021 | $-0.06 | $745.42M | $-25.25M | -3.4% |
| 2022 | $-0.08 | $766.55M | $-32.83M | -4.3% |
| 2023 | $-0.02 | $750.27M | $-8.87M | -1.2% |
| 2024 | $0.04 | $792.32M | $16.39M | 2.1% |
| 2025 | $0.09 | $796.85M | $30.44M | 3.8% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $0.32 | $0.27 – $0.38 | $764.76M | $755.1M – $767.14M | 9 |
| 2027 | $0.37 | $0.28 – $0.43 | $805.93M | $784.31M – $837.89M | 8 |
| 2028 | $0.44 | $0.11 – $0.82 | $866.61M | $866.61M – $866.62M | 6 |
| 2029 | $0.89 | $0.86 – $0.91 | $925.63M | $902.33M – $945.83M | 4 |
| 2030 | $0.00 | $0.00 – $0.00 | $914.8M | $891.76M – $934.76M | 2 |
